Home » Topics » Regulatory » Patents

Patents
RSS

Asta Medica investigates compounds for immune and allergic disorders

July 1, 1998

New antitumor agent disclosed in patent literature by Taisho

July 1, 1998

Modulators of the activity of IL-13 investigated at Amrad

July 1, 1998

Human Genome Sciences presents novel chemokine, its preparation and use

July 1, 1998

Astra devotes significant resources to development of immunomodulatory peptides

June 30, 1998

Factor Xa inhibitors developed by Boehringer Mannheim researchers

June 30, 1998

Boehringer Ingelheim presents new leukotriene antagonists

June 30, 1998

Inhibitors of Ras function patented by Schering-Plough

June 30, 1998

Modulators of drug/multidrug resistance from Lilly

June 29, 1998

Astra prepares another series of immunomodulatory peptides

June 29, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...